What's Behind the Numbers For Quest Diagnostics Incorporated (NYSE:DGX)?

Share

Therefore 37% are positive. Quest Diagnostics Incorporated has a 1-year low of $79.12 and a 1-year high of $112.96. Quest Diagnostics had 43 analyst reports since August 4, 2015 according to SRatingsIntel. Metropolitan Life Insur Com Ny, New York-based fund reported 65,879 shares. Canaccord Genuity maintained the stock with "Buy" rating in Monday, September 11 report. Canaccord Genuity has "Buy" rating and $11800 target. The rating was upgraded by Mizuho on Tuesday, January 3 to "Buy".

Quest Diagnostics Inc. was covered by a number of analysts recently, 2 rated the stock as Buy, 14 rated Hold, 0 rated sell and 1 gave an Underperform.

In other news, Chairman Stephen H. Rusckowski sold 59,235 shares of the business's stock in a transaction that occurred on Tuesday, September 12th. The rating was maintained by Mizuho on Thursday, October 22 with "Neutral". Finally, Wells Fargo & Company assumed coverage on Quest Diagnostics in a report on Thursday. Robert W. Baird maintained Quest Diagnostics Inc (NYSE:DGX) rating on Thursday, October 5. Cibc Ww Markets holds 0% of its portfolio in Quest Diagnostics Inc (NYSE:DGX) for 3,612 shares. Analysts had predicted $1.42. The rating was upgraded by Zacks on Tuesday, September 1 to "Sell". The stock of Merck & Co., Inc. The firm has "Buy" rating given on Monday, June 26 by Raymond James. Also, Director Jenne K. Britell sold 6,111 shares of Quest Diagnostics stock in a transaction dated Monday, April 24th. Shares for $83,262 were sold by Hong Chun K. The company had revenue of $1.94 billion during the quarter, compared to analysts' expectations of $1.94 billion. About 761,069 shares traded. It is down 13.66% since October 12, 2016 and is uptrending.

Investors sentiment decreased to 0.99 in Q2 2017. Its down 0.05, from 1.04 in 2017Q1. It fall, as 50 investors sold vehicle shares while 64 reduced holdings. 19 funds opened positions while 49 raised stakes. Ahl Llp has invested 0.02% of its portfolio in Evertec Inc (NYSE:EVTC). (NASDAQ:NLST) for 31,863 shares. Institutional investors own 87.10% of the company's stock. (NASDAQ:NLST). Awm Communication has 5.56M shares. Axa holds 0.02% or 236,500 shares in its portfolio. It also upped Netflix Inc (NASDAQ:NFLX) stake by 2,150 shares and now owns 7,516 shares. Advisory Serv Ntwk Llc owns 224 shares or 0% of their U.S. portfolio. (NASDAQ:NLST) for 18,103 shares. Etrade Mngmt Ltd Liability accumulated 0.1% or 24,478 shares. Huntington Bancshares has 0% invested in CyrusOne Inc (NASDAQ:CONE) for 500 shares. Exane Derivatives accumulated 16 shares.

Capital World Investors decreased its stake in Merck And Co Inc (MRK) by 10.8% based on its latest 2017Q2 regulatory filing with the SEC. State Of Alaska Department Of Revenue accumulated 103,855 shares. Twin Cap Mgmt stated it has 0.33% in Quest Diagnostics Inc (NYSE:DGX). Martingale Asset Limited Partnership stated it has 0.07% in Evertec Inc (NYSE:EVTC). (NASDAQ:CAR). State Street Corporation holds 0.01% of its portfolio in Avis Budget Group Inc. Vanguard Gp Incorporated reported 0.01% stake. (NASDAQ:NLST). Blackrock holds 0% or 172,371 shares. World Asset Management reported 0.05% of its portfolio in Quest Diagnostics Inc (NYSE:DGX). On average, analysts expect that Quest Diagnostics will post $5.66 earnings per share for the current fiscal year. CONE's profit will be $70.24 million for 20.15 P/E if the $0.77 EPS becomes a reality. Bank Of Mellon holds 0.04% in Quest Diagnostics Inc (NYSE:DGX) or 1.17M shares.

Relative strength index (RSI-14) for Quest Diagnostics Incorporated (DGX) is at 23.14. The company's market cap is $12.49 Billion, and the average volume is 1.02 Million. The Firm operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. Also, it has an estimated price-earnings (P/E) multiple of 15.57 and a trailing 12-month price-earnings (P/E) multiple of 18.3. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks, health plans, employers and accountable care organizations (ACOs).

Investors sentiment increased to 1.07 in 2017 Q2. Its down 0.05, from 1.04 in 2017Q1. 78 funds opened positions while 158 raised stakes. Schnieders Capital Management LLC now owns 2,366 shares of the medical research company's stock worth $263,000 after buying an additional 6 shares in the last quarter. Prudential Public Limited Liability Corp holds 0% or 11,300 shares in its portfolio. AJO LP now owns 2,134,245 shares of the medical research company's stock worth $237,243,000 after purchasing an additional 1,237,021 shares during the last quarter. Srs Ltd Com has 8.50 million shares. Rand Wealth Lc has 18,223 shares. Quest Diagnostics accounts for about 2.3% of Polaris Capital Management LLC's investment portfolio, making the stock its 11th largest holding. Moreover, Shell Asset Mngmt has 0.17% invested in Quest Diagnostics Inc (NYSE:DGX) for 62,096 shares. Swiss Savings Bank invested in 570,530 shares.

Quest Diagnostics (NYSE:DGX) last posted its earnings results on Tuesday, July 25th. M&R Capital Management invested in 924 shares. Moreover, Btim has 0.03% invested in Quest Diagnostics Inc (NYSE:DGX). Eagle Glob Ltd Liability holds 1,870 shares. Quest Diagnostics Inc has a 12-month low of $75.20 and a 12-month high of $108.89.

Share